Brain lymphoma
Showing 1 - 25 of >10,000
Malignant Tumors, Brain Lymphoma, CNS Lymphoma Trial in Seoul (Usefulness of Gadovist-enhanced FLAIR imaging in differentiation
Completed
- Malignant Tumors
- +2 more
- Usefulness of Gadovist-enhanced FLAIR imaging in differentiation between a glioblastoma and solitary brain metastasis
-
Seoul, Gurogu, Korea, Republic ofKorea University Guro Hospital
Mar 14, 2022
Cognitive Impairment in Young Patients With Cancer Prospectively
Recruiting
- Chemotherapy-Related Cognitive Impairment
- +9 more
-
Copenhagen, DenmarkRigshospitalet
Apr 24, 2023
Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +
Recruiting
- Melanoma
- +14 more
- LITT + Pembrolizumab
-
Gainesville, Florida
- +1 more
Aug 22, 2022
Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- +3 more
- Pemetrexed
- +3 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022
Non Hodgkin Lymphoma, Heart; Functional Disturbance, Hodgkin Lymphoma Trial in Winston-Salem, Richmond (other, diagnostic test,
Recruiting
- Non Hodgkin Lymphoma
- +3 more
- Exercise with Trainerize application
- +5 more
-
Winston-Salem, North Carolina
- +1 more
Feb 2, 2023
Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media
Recruiting
- Cancer
- +21 more
- Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 7, 2022
CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,
Active, not recruiting
- CNS Lymphoma
- +2 more
- Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
-
Basking Ridge, New Jersey
- +2 more
Jan 27, 2023
Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)
Recruiting
- Primary Central Nervous System Lymphoma
- +2 more
- Methotrexate
- +2 more
-
Guandong, Guangdong, China
- +2 more
Apr 6, 2022
Primary CNS Lymphoma Trial in Beijing (Camrelizumab)
Recruiting
- Primary Central Nervous System Lymphoma
-
Beijing, ChinaSanbo Brain Hospital Capital Medical University
Feb 10, 2022
Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,
Recruiting
- Childhood Non-Hodgkin Lymphoma
- +2 more
- Goal Management Training (GMT)
- Brain Health Workshop (BHW)
-
Oslo, Norway
- +2 more
May 25, 2022
Frailty in Young Adult Survivors of Childhood Cancer
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 8, 2022
Prospective Neurobehavioral Functions in Newly-diagnosed Primary
Recruiting
- Primary CNS Lymphoma
- Brain Lymphoma
- A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Mar 9, 2021
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Primary CNS Lymphoma Trial in Beijing (Orelabrutinib, Pomalidomide, Rituximab)
Recruiting
- Primary Central Nervous System Lymphoma
- Orelabrutinib
- +3 more
-
Beijing, Beijing, China
- +2 more
May 19, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Primary CNS Lymphoma Trial in Paris ([18F]-FDG PET/MR)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- [18F]-FDG PET/MR
-
Paris, FrancePitié Salpêtrière Hospital
Sep 9, 2021
Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)
Terminated
- Lymphoma
- +15 more
- Genistein
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia
Feb 8, 2022
Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)
Recruiting
- Pediatric Solid Tumor
- +7 more
- CLR 131
-
Palo Alto, California
- +6 more
Nov 30, 2021
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric Trial in Canada, United States (BMS-986158, BMS-986378)
Recruiting
- Solid Tumor, Childhood
- +2 more
-
Boston, Massachusetts
- +5 more
Dec 27, 2022
European Prospective Investigation Into Childhood Cancer
Not yet recruiting
- Establish Biobanking Initiative Among Southern European Children and Adolescents With Acute Lymphoblastic Leukemia and Favorable Biology Brain Tumors
- Observational
- (no location specified)
May 11, 2022
After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
- Central Nervous System Lymphoma
- +5 more
- Magnetic Resonance Imaging
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 12, 2021
Refractory and Relapsed Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guangzhou (Orelabrutinib, Thiotepa)
Not yet recruiting
- Refractory and Relapsed Primary CNS Lymphoma
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Aug 19, 2021